申请人:Kureha Chemical Industry Co., Ltd.
公开号:EP1273571A1
公开(公告)日:2003-01-08
The present invention provides novel compounds having antiviral activities and antiviral drugs containing the compounds as the active ingredient. The compounds are shown by the following general formula (1),
wherein typically A1 and A2 are each guanidine or a group of the general fomula (ia) ; A3 is a mono- or poly-cyclic heteroaromatic ring contining 1 or 2 heteroatoms ; B1 is a single bond or alkylene group; R1 is hydrogen or alkyl group; W is an alkylene having 2-3 carbons, a cycloalkylene having 5-10 carbons, aromatic ring having 6-10 carbons, or a heteroaromatic ring having 5-10 carbons; y is C(=O)-; x is -C(=O)-NH-; n1 is an integer of 1-2; n2 is an integer of 2-3; D is a substituent selected from among various groups.
本发明提供了具有抗病毒活性的新化合物以及含有这些化合物作为活性成分的抗病毒药物。这些化合物由以下一般式(1)所示,其中通常A1和A2分别是胍或一般式(ia)的基团;A3是含有1个或2个杂原子的单环或多环杂芳环;B1是单键或烷基基团;R1是氢或烷基基团;W是具有2-3个碳的烷基、具有5-10个碳的环烷基、具有6-10个碳的芳香环或具有5-10个碳的杂芳环;y是C(=O)-;x是-C(=O)-NH-;n1是1-2的整数;n2是2-3的整数;D是从各种基团中选择的取代基。